# Study to Evaluate the Safety and Immunogenicity of a 10-valent Pneumococcal Conjugate Vaccine in Preterm Infants

> **NCT00390910** · PHASE3 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 286 (actual)

## Conditions studied

- Infections, Streptococcal

## Interventions

- **BIOLOGICAL:** Pneumococcal conjugate vaccine GSK1024850A
- **BIOLOGICAL:** Infanrix hexa

## Key facts

- **NCT ID:** NCT00390910
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-10-01
- **Primary completion:** 2007-07-02
- **Final completion:** 2008-05-02
- **Target enrollment:** 286 (ACTUAL)
- **Last updated:** 2018-12-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00390910

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00390910, "Study to Evaluate the Safety and Immunogenicity of a 10-valent Pneumococcal Conjugate Vaccine in Preterm Infants". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00390910. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*